BioMarin Announces the Ministry of Health, Labor and Welfare (MHLW) in Japan Granted Approval for VOXZOGO® (vosoritide) for Injection for the Treatment of Children with Achondroplasia, Whose Growth Plates are Not Closed

On June 21, 2022

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219

Related Post

Federal Realty Investment Trust Announces Second Quarter 2022 Earnings Release Date and Conference Call Information

Mattel Announces Second Quarter 2022 Financial Results Conference Call

KLA Corporation Announces Pricing of Tender Offer